schizandrin b has been researched along with ku 55933 in 2 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (ku 55933) | Trials (ku 55933) | Recent Studies (post-2010) (ku 55933) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 164 | 0 | 127 |
| Protein | Taxonomy | schizandrin b (IC50) | ku 55933 (IC50) |
|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.458 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | 0.133 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 7.44 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.4943 | |
| Serine-protein kinase ATM | Homo sapiens (human) | 0.191 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charrier, JD; Durrant, SJ; Golec, JM; Kay, DP; Knegtel, RM; MacCormick, S; Mortimore, M; O'Donnell, ME; Pinder, JL; Pollard, JR; Reaper, PM; Rutherford, AP; Wang, PS; Young, SC | 1 |
| Finlay, MR; Griffin, RJ | 1 |
1 review(s) available for schizandrin b and ku 55933
| Article | Year |
|---|---|
Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA; DNA Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins | 2012 |
1 other study(ies) available for schizandrin b and ku 55933
| Article | Year |
|---|---|
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.
Topics: Amino Acid Sequence; Antineoplastic Agents; Catalytic Domain; Drug Discovery; Models, Molecular; Molecular Sequence Data; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazines; Structure-Activity Relationship; Substrate Specificity; Sulfones | 2011 |